CHG-2024-0225

Facility Change for Haemoferrin. Facility Change for Haemoferrin — major revision. Impacts 5 markets and 5 variations.

Change Number
CHG-2024-0225
Type
Facility Change
Product
Haemoferrin
Status
Submitted
Owner
Dmitri Volkov
Initiated
2023-07-31
Description

Facility Change for Haemoferrin — major revision

Impacted Markets (5)
NL — NetherlandsTW — TaiwanTR — TurkeySA — Saudi ArabiaDK — Denmark
Impacted Modules
4.2.12.3.P3.2.S
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved